53
41
Growth Score
-13 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
663721
Sofar develops its own line of products, expanding its production to include dietary supplements and medical devices.
Acquired by 
Fine Foods & Pharmaceuticals Ntm
- Andrea Biffi: Chief Executive Officer
Ksks Udud: Co-CEO
Alfasigma
About the Company
Sofar develops its own line of products, expanding its production to include dietary supplements and medical devices.
In 1985 Sofar launches Sofargen, a topical dressing containing silver sulfadiazine. The WHO places it on its list of 200 essential drugs. It was followed by some more products that they developed during their years of
experimentation. Such products may include Pensacola, Enterolactis, Cistiflu, and many more.
SOFAR AMERICAS Inc. is established in the USA in the year 2016.
